TMP Medical’s MISSIONS

We introduce technologies to highly complicated medical front to make data-based decision making be natural.

We apply technologies to connect the information that remains at each front and create a foundation for the entire medical industry.

Data is to handed over from a front to another front, then to patient, finally to society. Such circulation must play a big role to save lives.

Medical system can save lives which could not be spared in medical front.

Three burdens in medical fronts caused by fragmentated medical data: for patients, medical professions and society.

Patient data is closed in each front

The fragmentated medical data is responsible for sigificant cost of sharing information among medical professions as well as for big burden of patients such as overlapped medical examinations and questionings. Unified management of medical data on cloud system enables relevant information to be shared smoothly among hospitals. And returning the data to patients enables them to keep their own data.

Long waiting time in hospitals

In after-hours outpatient section of hospitals, operations are not effective so patients must wait for long time. It is because patients are repeatedly treated in a haphazard manner according to their actual symptoms. Mutual visualization of patients’ symptoms, congestion situation and human resources enables to construct effective operation for both patients and medical workers.

Absence of data-based decision making

Emergncy medical care is the connecting point between hospitals and society, and it also plays essential role as social infrastructure. Racing patients to hospitals as soon as possible is a top priority issue, of course, but on the other hand, outcome evaluation after medical treatments is impossible due to lack of data. We pursue to actualize emergency medical care with improved “outcome”as well as “speed”, by making data-based decision making become normal.

Products

Emergency System

This integrated platform supports both medical record input and reseach at the same time, and it has the largest share in emergency unit class, large hospitals.

The system provides Emergency Medical Teams with a mobile application that allows them to input patient information using voice commands and image OCR. And patients’ information can be shared through cloud system that leads smooth information sharing between Emergency Medical Team and hospital.

Self Assessment System

This is a Self Assessment System. With the system, patients can input their data on their smartphones or tablets,the data can be imported to electronic medical chart and interview system can be customized.

Introduction of our board members

Chief Executive Officer (doctor)

Tomohiro Sonoo

Graduated from the University of Tokyo School of Medicine.Engaged mainly in clinical work in emergency intensive care at the University of Tokyo Hospital and Hitachi General Hospital.Emergency medicine specialist and intensivist.In addition to the clinical work, he has developed acute care databases and conducted several studies related to these databases.34 original papers in English (September 2020 point in time). He founded TXP Medical in August 2017, after commercializing the emergency medical information system NEXT Stage ER, which he developed by himself. He continues to actively communicate to academia and industry regarding the appropriate use of IT in the medical field.

Chief Operating Officer

Atsushi Onda

Graduated from the School of Science and Engineering, Waseda University.Worked in Accenture Strategy Group and Analytics Group on business strategy, operational reform, and big data related projects focusing on mobile, medical device, government, and energy industries. Before assuming his current position,He also worked at JMDC for developing new business and leading medical big data analysis projects, mainly for the life insurance industry and medical insurers.

Board Member

Kazuki Okuma

Graduated from School of Law, Keio University.After completing his legal training, he registered as a lawyer. He handles corporate legal matters for a wide range of industries, from startups to publicly traded companies. His strength lies in legal research for mergers and acquisitions and new services for pre- and post-listing ventures, and focuses on promoting innovative business based on the law.

Chief Scientific Officer

Tadahiro Goto

Graduated from the University of Fukui Faculty of Medicine.Trained in the Emergency Department of the same hospital. He was a core member of the Emergency Medicine Alliance and the Japanese Emergency Medicine Network.After obtaining his emergency medicine residency, he went on to complete a master's degree at Harvard School of Public Health (graduated in 2016) and three years of clinical research in the Emergency Department at Massachusetts General Hospital.After coming back to Japan, he conducted research at the University of Tokyo Graduate School of Clinical Epidemiology and Economics, and currently serves as CSO of TXP Medical, where he conducts data analysis and supervises clinical research.

Outside Board Director/ITOCHU CORPORATION
General Manager of Frontier Business Department

Tetsuya Asano

Graduated from Kyoto University, Faculty of Letters, and joined ITOCHU Corporation. After working for a system integrator, stationed in New York, seconded to a healthcare management service company, seconded to a pharmaceutical marketing company (as a director), worked as the General Manager of the Information & Telecommunication Division's Planning Supervisory Section, and served as the General Manager of the Information Industry Business Department, he assumed his current position in April 2022. Since joining the company, he has been consistently involved in business development, investment, and corporate planning in the IT and healthcare fields.

Outside Director / Principal, UTEC

Hiroaki Kobayashi

Graduated from the University of Tokyo School of Medicine. Engaged in clinical work in emergency intensive care at the University of Tokyo Hospital and other hospitals.Obtained Emergency Medicine Specialist. In 2014, he joined a medical device startup in its founding phase to promote business launches in Japan and abroad.After obtaining his Master of Business Administration (MBA) from the University of Michigan, USA in 2018, he joined UTEC in 2019 and is responsible for investments in the Life Sciences and Healthcare area.

Auditor / Director and Partner, UTEC

Noriaki Sakamoto

After graduating from the University of Tokyo, Faculty of Economics, he joined the Ministry of Economy, Trade and Industry. Retired from the Ministry of Economy, Trade and Industry (METI) in 2008. After managing a distribution business company, a family business, he earned an MBA from Columbia University, worked as a manager at McKinsey & Company, and joined UTEC in August 2014. He supported the Grand Prize and Excellence Award winning projects of NEDO TCP in 2015 and the IoT Lab Selection Grand Prix project of the Ministry of Economy, Trade and Industry in 2016, and also supported the Grand Prize in the Entrepreneurship Challenge 2017.

ADVISER

Consultant

Shinichiro Katayanagi

Graduated from the Department of Political Science, Faculty of Law, Keio University.After building a career in the overseas business sales department of Nihon Cement (now Taiheiyo Cement), he moved to Yamanouchi Pharmaceutical (now Astellas Pharma Inc.) in 1991. After working in the corporate planning and finance departments, he was stationed in Europe, where he gained experience in accounting, finance, and management system development at the European headquarters. After returning to Japan in 2001, he participated in the merger project with Fujisawa Pharmaceutical as a core member and realized the creation of the new Astellas company. After that, he was appointed General Manager of the Asia Business Division, overseeing the company's Asia-Oceania operations in 2009. In 2015, he joined Toho Holdings, a major pharmaceutical wholesaler, to lead the company's overseas business expansion as its executive officer. He joined Dainippon Sumitomo Pharma in 2016. mainly in charge of the U.S. business and in 2020 became Chairman of the U.S. subsidiary of Dainippon Sumitomo Pharma, where he oversaw operations and administration.He has been in his current position since April 2021.